186 related articles for article (PubMed ID: 19998046)
41. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial.
Togni S; Maramaldi G; Bonetta A; Giacomelli L; Di Pierro F
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1338-44. PubMed ID: 25967706
[TBL] [Abstract][Full Text] [Related]
42. Sucralfate cream in the management of moist desquamation during radiotherapy.
Delaney G; Fisher R; Hook C; Barton M
Australas Radiol; 1997 Aug; 41(3):270-5. PubMed ID: 9293679
[TBL] [Abstract][Full Text] [Related]
43. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
Pignol JP; Olivotto I; Rakovitch E; Gardner S; Sixel K; Beckham W; Vu TT; Truong P; Ackerman I; Paszat L
J Clin Oncol; 2008 May; 26(13):2085-92. PubMed ID: 18285602
[TBL] [Abstract][Full Text] [Related]
44. Skin toxicity during breast irradiation: pathophysiology and management.
Harper JL; Franklin LE; Jenrette JM; Aguero EG
South Med J; 2004 Oct; 97(10):989-93. PubMed ID: 15558927
[TBL] [Abstract][Full Text] [Related]
45. Use of axillary deodorant and effect on acute skin toxicity during radiotherapy for breast cancer: a prospective randomized noninferiority trial.
Théberge V; Harel F; Dagnault A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1048-52. PubMed ID: 19327906
[TBL] [Abstract][Full Text] [Related]
46. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores.
Hoeller U; Tribius S; Kuhlmey A; Grader K; Fehlauer F; Alberti W
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1013-8. PubMed ID: 12605981
[TBL] [Abstract][Full Text] [Related]
47. Prevention and therapy of radiation-induced bowel discomfort.
Henriksson R; Franzén L; Littbrand B
Scand J Gastroenterol Suppl; 1992; 191():7-11. PubMed ID: 1411296
[TBL] [Abstract][Full Text] [Related]
48. Topical use of Jiawei Simiao Yongan Gao to prevent radiodermatitis in patients with head and neck cancer: A retrospective cohort study.
Song F; Liao Z; Li T; Kang N; Li Z; Fan S; Liu F
Medicine (Baltimore); 2020 Nov; 99(48):e23318. PubMed ID: 33235092
[TBL] [Abstract][Full Text] [Related]
49. RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements.
Huang CJ; Hou MF; Luo KH; Wei SY; Huang MY; Su SJ; Kuo HY; Yuan SS; Chen GS; Hu SC; Chuang HY
Breast; 2015 Jun; 24(3):230-6. PubMed ID: 25777626
[TBL] [Abstract][Full Text] [Related]
50. [Efectiveness of topical therapies in patients with breast cancer that experience radiodermatitis. A systematic review].
Fernández-Castro M; Martín-Gil B
Enferm Clin; 2015; 25(6):327-43. PubMed ID: 26475084
[TBL] [Abstract][Full Text] [Related]
51. The Impact of Radiodermatitis on Breast Cancer Patients' Quality of Life During Radiotherapy: A Prospective Cohort Study.
Fuzissaki MA; Paiva CE; Oliveira MA; Lajolo Canto PP; Paiva Maia YC
J Pain Symptom Manage; 2019 Jul; 58(1):92-99.e1. PubMed ID: 30974233
[TBL] [Abstract][Full Text] [Related]
52. Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient?
Haffty BG; Buchholz TA; McCormick B
J Clin Oncol; 2008 May; 26(13):2072-4. PubMed ID: 18285600
[No Abstract] [Full Text] [Related]
53. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13.
Fisher J; Scott C; Stevens R; Marconi B; Champion L; Freedman GM; Asrari F; Pilepich MV; Gagnon JD; Wong G
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1307-10. PubMed ID: 11121627
[TBL] [Abstract][Full Text] [Related]
54. No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions--results from a randomised blinded trial.
Sharp L; Finnilä K; Johansson H; Abrahamsson M; Hatschek T; Bergenmar M
Eur J Oncol Nurs; 2013 Aug; 17(4):429-35. PubMed ID: 23245940
[TBL] [Abstract][Full Text] [Related]
55. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study.
Makkonen TA; Minn H; Jekunen A; Vilja P; Tuominen J; Joensuu H
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):525-34. PubMed ID: 10701730
[TBL] [Abstract][Full Text] [Related]
56. Pharmacotherapy for chronic hemorrhagic radiation proctitis.
Gul YA; Prasannan S; Jabar FM; Shaker AR; Moissinac K
World J Surg; 2002 Dec; 26(12):1499-502. PubMed ID: 12297939
[TBL] [Abstract][Full Text] [Related]
57. Topical antioxidants in radiodermatitis: a clinical review.
Kodiyan J; Amber KT
Int J Palliat Nurs; 2015 Sep; 21(9):446-52. PubMed ID: 26412275
[TBL] [Abstract][Full Text] [Related]
58. Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients.
Robijns J; Censabella S; Claes S; Pannekoeke L; Bussé L; Colson D; Kaminski I; Lodewijckx J; Bulens P; Maes A; Noé L; Brosens M; Timmermans A; Lambrichts I; Somers V; Mebis J
Support Care Cancer; 2019 Apr; 27(4):1245-1254. PubMed ID: 30270415
[TBL] [Abstract][Full Text] [Related]
59. Sucralfate in the prevention of radiation-induced oral mucositis.
Cengiz M; Ozyar E; Oztürk D; Akyol F; Atahan IL; Hayran M
J Clin Gastroenterol; 1999 Jan; 28(1):40-3. PubMed ID: 9916664
[TBL] [Abstract][Full Text] [Related]
60. Topical betamethasone for prevention of radiation dermatitis.
Omidvari S; Saboori H; Mohammadianpanah M; Mosalaei A; Ahmadloo N; Mosleh-Shirazi MA; Jowkar F; Namaz S
Indian J Dermatol Venereol Leprol; 2007; 73(3):209. PubMed ID: 17561562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
